- Home
- OLN vs HCM Comparison
OLN vs HCM Comparison
Compare OLN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLN | HCM |
|---|---|---|
| Founded | 1892 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OLN | HCM |
|---|---|---|
| Price | $20.34 | $13.55 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 14 | 1 |
| Target Price | ★ $24.29 | $13.75 |
| AVG Volume (30 Days) | ★ 2.5M | 21.1K |
| Earning Date | 01-29-2026 | 08-07-2025 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.47 | ★ 0.53 |
| Revenue | ★ $6,787,000,000.00 | $602,197,000.00 |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $2.15 | $15.54 |
| P/E Ratio | $43.81 | ★ $4.90 |
| Revenue Growth | ★ 4.68 | N/A |
| 52 Week Low | $17.66 | $11.51 |
| 52 Week High | $34.76 | $19.50 |
Technical Indicators
Market Signals| Indicator | OLN | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 45.94 | 35.07 |
| Support Level | $20.05 | $13.06 |
| Resistance Level | $20.74 | $13.79 |
| Average True Range (ATR) | 0.94 | 0.23 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 9.59 | 32.91 |
Price Performance
Historical ComparisonAbout OLN Olin Corporation
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.